CHERYL STONE: Open Payments
NPI 1457348245 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$418 in 24 payments from 7 companies in 2025. Trend: 2023 $988 · 2024 $556 · 2025 $418
Food & beverage: $418
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 14 | $145 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $123 |
| Impulse Dynamics (USA) Inc. | 2 | $41 |
| Regeneron Healthcare Solutions, Inc. | 2 | $34 |
| Novo Nordisk Inc | 2 | $31 |
| Abbott Laboratories | 1 | $25 |
| Ionis Pharmaceuticals, Inc. | 1 | $19 |
Products named: REPATHA, JARDIANCE, Optimizer, EVKEEZA, Wegovy, CARDIOMEMS.
Industry payments across OK — which companies pay providers there.
